Skip to main content
  1. aggrego TV
  2. Graft Versus Host Disease

Improving Patient Access to Therapies for Chronic Graft vs Host Disease

Recommended
PTCy, Tacrolimus, and Mycophenolate Mofetil as GvHD Prophylaxis
Comparing 1-Year OS and RFS in Patients Treated With ABA in Combination With a CNI/MTX vs ATG or PT-Cy Following Allogenic HCT
Impact of GVHD Prophylaxis on CMV Reactivation and Disease After HLA-Matched Peripheral Blood Stem Cell Transplantation
The Clinical Impact of Donor Against Recipient HLA One Way Mismatch on the Occurrence of Graft versus Host Disease in Liver Transplantation
A Phase 1 Study of Donor Regulatory T-Cell Infusion Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
Novel Haploidentical Bone Marrow Transplantation Approach Effective in Relapsed/Refractory Severe Aplastic Anemia
Treatment Options for Patients With Chronic Graft vs Host Disease
Understanding Symptom Burden, Disease Severity in Graft vs Host Disease

Improving Patient Access to Therapies for Chronic Graft vs Host Disease

header-info
Sep, 19, 2022
social-elements

Meilin Diaz-Paez, MSN, APRN, FNP-BC, AOCNP, BMTCN, advanced practice registered nurse, Division of Transplantation & Cellular Therapy, University of Miami Sylvester Comprehensive Cancer Center, describes what payers should know about patients with chronic graft vs host disease, including barriers that prevent access to timely care.

This interview is part of the series, "Current Treatments and Unmet Need in Chronic Graft vs Host Disease."

Footer branding


Footer main navigation

  • About Us
  • Contact Us
  • Privacy Policy
  • Sign in

HMP Global Products

  • HMP Global Learning Network
  • Consultant360
  • VRTX

Copyright branding

© 2023 HMP Global. Aggrego is a trademark of HMP Global. All Rights Reserved.

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->

Home

Site branding - mobile

Upper navigation

  • Today
    Today
  • Following
    Following
  • Specialties
    Specialties

Main navigation

  • News
    news
  • TV
    TV
  • Radio
    Radio
  • Conference Hub
    Conf hub
  • Originals
    Originals

Partners links

  • Advances
    Advances

User imageSign in

Register

Additional navigation- 1

  • Acute Basal Cell Carcinoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Breast Cancer
  • Early Breast Cancer
  • CAR-T Cell Therapy
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous Squamous-Cell Carcinoma
  • Diffuse Large B-Cell Lymphoma
  • FDA Approvals
  • Febrile Neutropenia
  • Follicular Lymphoma
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Gynecologic Cancer
  • Head and Neck Cancer
  • Healthcare Policy
  • Hematologic Malignancies
  • Immuno Oncology
  • Liver Cancer
  • Lung Cancer
  • Lymphoma
  • Multiple Myeloma
  • Myelofibrosis
  • Non-Small Cell Lung Cancer
  • Oncology Nursing
  • Pediatric Oncology
  • Radiation Oncology
  • Renal Cell Carcinoma
  • Sarcoma
  • Supportive Care
  • Surgical Oncology
  • Urethral Carcinoma